Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis Mohamed Zebouh, Caroline Thomas, Patrick Honderlick, Ludovic Lemee, Christine Segonds, Frédéric Wallet, Marie-Odile Husson Journal of Cystic Fibrosis Volume 7, Issue 3, Pages 238-243 (May 2008) DOI: 10.1016/j.jcf.2007.10.002 Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions
Fig. 1 Cumulative percentage of global MICs (mg/mL) of ticarcillin, ceftazidime, imipenem, aztreonam, tobramycin and ciprofloxacin inhibiting all Gram-negative bacteria. Journal of Cystic Fibrosis 2008 7, 238-243DOI: (10.1016/j.jcf.2007.10.002) Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions
Fig. 2 Cumulative percentage of global MICs (mg/mL) of ticarcillin, ceftazidime, imipenem, aztreonam, tobramycin and ciprofloxacin inhibiting all Gram-negative bacteria. Journal of Cystic Fibrosis 2008 7, 238-243DOI: (10.1016/j.jcf.2007.10.002) Copyright © 2007 European Cystic Fibrosis Society Terms and Conditions